Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model

Alzheimer's disease represents one of the greatest medical challenges of our time, affecting millions of people worldwide with progressive loss of cognitive ability and memory. This neurodegenerative condition is characterized mainly by the formation of amyloid plaques in the brain, altered tau proteins, and an inflammatory process that damages nerve cells. Although several drugs have been developed to attempt to combat these characteristic disease changes, no truly effective treatment yet exists to halt or significantly reverse its progression. In this context, complementary therapies such as acupuncture have aroused growing interest in the medical community, especially electroacupuncture, which combines traditional acupuncture techniques with low-intensity electrical stimuli.

To better investigate how electroacupuncture might benefit Alzheimer's patients, researchers developed an experimental study using mice genetically modified to develop characteristics similar to the human disease. These animals, known as 5XFAD, present brain alterations that reproduce many aspects observed in people with Alzheimer's, including memory problems, formation of amyloid plaques, and brain inflammation. The main objective was to understand how electroacupuncture specifically influences cognitive ability and inflammatory processes in the brain. The researchers applied treatment at the KI-3 acupuncture point, located on the foot, known in traditional Chinese medicine for its relation to cognitive functions.

For two weeks, the animals received 15-minute sessions with low-intensity electrical stimulation, three times per week. To assess results, several behavioral tests were performed to measure memory and learning ability, in addition to detailed analyses of brain tissue to identify molecular and cellular changes.

The results obtained were particularly encouraging and revealed multiple benefits of electroacupuncture. In working memory tests, which assess the ability to recognize new objects compared with familiar ones, treated animals showed significant improvement compared with untreated ones. Interestingly, this improvement was more evident for cortex-related functions than for hippocampal-dependent ones, suggesting that the treatment acts preferentially on certain brain regions. Using an advanced brain imaging technique called microPET, the researchers confirmed that electroacupuncture increased energy metabolism in the frontal cortex and hypothalamus, regions important for memory and energy regulation.

At the cellular level, significant reductions were observed in inflammation markers, such as proteins released by activated microglia and astrocytes, which normally contribute to neural damage in Alzheimer's disease. Additionally, treatment increased the production of proteins important for synaptic function — the connections between neurons — and improved the microscopic structure of these connections. Perhaps most impressive was the discovery that electroacupuncture reduced the amount of toxic amyloid proteins accumulated in the brain, particularly in the frontal cortex.

These findings have important implications for both patients and healthcare professionals. For Alzheimer's patients and their families, the results suggest that electroacupuncture may represent a safe and potentially beneficial complementary therapy, especially for preserving certain cognitive functions such as working memory. The fact that the treatment demonstrated anti-inflammatory effects in the brain is particularly relevant, since chronic inflammation is recognized as an important factor in disease progression. For healthcare professionals, especially neurologists and geriatricians, these findings offer more solid scientific evidence to consider including electroacupuncture in multidisciplinary treatment protocols.

The discovery that treatment can positively influence brain metabolism and reduce accumulation of toxic proteins adds scientific credibility to a practice traditionally viewed with skepticism by conventional medicine. This is especially important considering that current pharmacologic treatments for Alzheimer's have limited efficacy and frequently present significant side effects.

It is important to acknowledge some important limitations of this study that should be considered when interpreting the results. First, the research was conducted in animal models, and although 5XFAD mice reproduce many characteristics of human Alzheimer's disease, not all aspects are identical, especially considering evolutionary differences between species. The treatment period was relatively short — only two weeks — leaving open questions about the effects of longer treatments and the durability of the observed benefits. Additionally, improvements were more evident in certain types of memory than others, suggesting that efficacy may be specific to certain cognitive functions.

Clinical studies in humans will be essential to confirm whether these benefits effectively translate to real patients. Another aspect to consider is that the study focused on a single specific acupuncture point, and it is possible that different point combinations or treatment protocols may produce different results. Despite these limitations, this work represents a significant advance in scientific understanding of how electroacupuncture may benefit neurodegenerative conditions, providing a solid basis for future clinical investigations and offering hope for the development of more effective and integrated therapeutic approaches for Alzheimer's disease patients.